Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview

Sigilon Therapeutics

31/07/2023 13:00

* Sigilon Therapeutics Inc  SGTX.OQ   SGTX.O  is expected
to show
a rise in quarterly revenue when it reports  results on August 2
(estimated). 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 47.4% increase in revenue to $4.25 million from $2.88 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Sigilon
Therapeutics Inc
is for a loss of $4.71 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sigilon
Therapeutics Inc is $30​, above​ its last closing price
of $21.28. ​​​

This summary was machine generated July 31 at 12:00 GMT.  All
figures in US dollars  unless otherwise stated